The Development and Evaluation of Sleep Intervention for Perinatal Family
1 other identifier
interventional
600
0 countries
N/A
Brief Summary
Background: Sleep disruptions and disturbances are highly prevalent among new mothers and fathers and negatively affect their mental health and infant development outcomes. Effective sleep interventions are vital for family health. Objectives: To develop a sleep intervention for mother-father-infant triads, and to evaluate the effects on sleep improvement, emotional distress, and infant health outcomes. Methods: In this proposal, we plan to conduct a parallel-group two-arm randomized controlled trial on pregnant women and their partners. Mother-father-infant triads will be recruited and randomly allocated to the intervention group (receiving a sleep intervention) or the control group. Data will be collected with repeated measures, and the relationship between studied variables will be analyzed with descriptive and inferential statistics. Anticipatory results: The development and evaluation of an evidence-based sleep intervention will provide a scientific insight into sleep care for pregnant women and their families.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2024
CompletedFirst Posted
Study publicly available on registry
July 5, 2024
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
January 14, 2025
January 1, 2025
9 months
June 13, 2024
January 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insomnia Severity Index
The Chinese version of the Insomnia Severity Index (ISI) is used to measure the severity of insomnia symptoms, a higher score indicates more severe insomnia symptoms.
baseline, at 36-weeks' gestation, 2-week postpartum, 1-month, 3-month,6-month, and 12-month postpartum
Secondary Outcomes (14)
Sleep quality
baseline, at 36-weeks' gestation, postpartum 1 month, 3 months, 6 months, and 12-months
Sleep duration using actigraphy
baseline, postpartum 1 month, 3 months, and 6 months.
Sleep sleep onset latency using actigraphy
baseline, postpartum 1 month, 3 months, and 6 months.
Sleep efficacy using actigraphy
baseline, postpartum 1 month, 3 months, and 6 months.
Wake after sleep onset using actigraphy
baseline, postpartum 1 month, 3 months, and 6 months.
- +9 more secondary outcomes
Study Arms (2)
sleep intervention
EXPERIMENTALParticipants in the intervention group will receive both the standardized usual care and the sleep intervention. The intervention consists of sleep education, health professional support, and counseling. The intervention will be delivered from pregnancy to postpartum for mothers and fathers.
Control
ACTIVE COMPARATORParticipants in the control group will receive a perinatal health booklet in addition to the standardized usual care.
Interventions
At the beginning of the intervention, participants will have an orientation and overview of the program. Then, participants will follow the curriculum of modules, and professional feedback to complete the intervention.
Participants in control group will follow standardized usual care and a perinatal health booklet
Eligibility Criteria
You may qualify if:
- First-time mothers and their partners aged 20 and older;
- Currently 30 weeks gestation or more, singleton;
- insomnia severity index score greater than 10;
- living with a husband or partner;
- Both women and their partners are willing to participate in and adhere to the research protocol;
- be able to read and speak the Mandarin language
You may not qualify if:
- sleep disorders, depression or anxiety disorders;
- medical diseases with abnormal heart rate variability, or arrhythmia;
- taking medicines that may affect the autonomic nervous system or
- night shift workers;
- obstetric complications, including gestational hypertension, preterm labor, labor complications, or postpartum complications;
- infants with fetal deformity, or neonatal complications;
- no access to Internet resources
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shu-Yu Kuo, Phd
Taipei Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2024
First Posted
July 5, 2024
Study Start
December 1, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
January 14, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share